SEOM clinical guidelines for anaemia treatment in cancer patients (2020)

Anaemia is defined by the presence of haemoglobin (Hb) levels < 13 g/dL in men and 12 g/dL in women. Up to 39% of cancer patients present it at the time of diagnosis and up to 40% have iron deficiency. Anaemia causes fatigue, functional deterioration and a reduction in the quality of life; it has...

Descripción completa

Detalles Bibliográficos
Autores principales: Escobar Álvarez, Y., de las Peñas Bataller, R., Perez Altozano, J., Ros Martínez, S., Sabino Álvarez, A., Blasco Cordellat, A., Brozos Vázquez, E., Corral Jaime, J., García Escobar, I., Beato Zambrano, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Clinical Guides in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057996/
https://www.ncbi.nlm.nih.gov/pubmed/33768441
http://dx.doi.org/10.1007/s12094-021-02580-2
_version_ 1783680940881477632
author Escobar Álvarez, Y.
de las Peñas Bataller, R.
Perez Altozano, J.
Ros Martínez, S.
Sabino Álvarez, A.
Blasco Cordellat, A.
Brozos Vázquez, E.
Corral Jaime, J.
García Escobar, I.
Beato Zambrano, C.
author_facet Escobar Álvarez, Y.
de las Peñas Bataller, R.
Perez Altozano, J.
Ros Martínez, S.
Sabino Álvarez, A.
Blasco Cordellat, A.
Brozos Vázquez, E.
Corral Jaime, J.
García Escobar, I.
Beato Zambrano, C.
author_sort Escobar Álvarez, Y.
collection PubMed
description Anaemia is defined by the presence of haemoglobin (Hb) levels < 13 g/dL in men and 12 g/dL in women. Up to 39% of cancer patients present it at the time of diagnosis and up to 40% have iron deficiency. Anaemia causes fatigue, functional deterioration and a reduction in the quality of life; it has also been associated with a poorer response to anti-tumour treatment and lower survival. Basic diagnostic tests for anaemia are simple and should be a routine part of clinical practice. These guidelines review the available evidence on the use of different therapies for treating anaemia: erythropoiesis-stimulating agents, iron supplements, and transfusion of blood products.
format Online
Article
Text
id pubmed-8057996
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80579962021-05-05 SEOM clinical guidelines for anaemia treatment in cancer patients (2020) Escobar Álvarez, Y. de las Peñas Bataller, R. Perez Altozano, J. Ros Martínez, S. Sabino Álvarez, A. Blasco Cordellat, A. Brozos Vázquez, E. Corral Jaime, J. García Escobar, I. Beato Zambrano, C. Clin Transl Oncol Clinical Guides in Oncology Anaemia is defined by the presence of haemoglobin (Hb) levels < 13 g/dL in men and 12 g/dL in women. Up to 39% of cancer patients present it at the time of diagnosis and up to 40% have iron deficiency. Anaemia causes fatigue, functional deterioration and a reduction in the quality of life; it has also been associated with a poorer response to anti-tumour treatment and lower survival. Basic diagnostic tests for anaemia are simple and should be a routine part of clinical practice. These guidelines review the available evidence on the use of different therapies for treating anaemia: erythropoiesis-stimulating agents, iron supplements, and transfusion of blood products. Springer International Publishing 2021-03-25 2021 /pmc/articles/PMC8057996/ /pubmed/33768441 http://dx.doi.org/10.1007/s12094-021-02580-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Clinical Guides in Oncology
Escobar Álvarez, Y.
de las Peñas Bataller, R.
Perez Altozano, J.
Ros Martínez, S.
Sabino Álvarez, A.
Blasco Cordellat, A.
Brozos Vázquez, E.
Corral Jaime, J.
García Escobar, I.
Beato Zambrano, C.
SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
title SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
title_full SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
title_fullStr SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
title_full_unstemmed SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
title_short SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
title_sort seom clinical guidelines for anaemia treatment in cancer patients (2020)
topic Clinical Guides in Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057996/
https://www.ncbi.nlm.nih.gov/pubmed/33768441
http://dx.doi.org/10.1007/s12094-021-02580-2
work_keys_str_mv AT escobaralvarezy seomclinicalguidelinesforanaemiatreatmentincancerpatients2020
AT delaspenasbatallerr seomclinicalguidelinesforanaemiatreatmentincancerpatients2020
AT perezaltozanoj seomclinicalguidelinesforanaemiatreatmentincancerpatients2020
AT rosmartinezs seomclinicalguidelinesforanaemiatreatmentincancerpatients2020
AT sabinoalvareza seomclinicalguidelinesforanaemiatreatmentincancerpatients2020
AT blascocordellata seomclinicalguidelinesforanaemiatreatmentincancerpatients2020
AT brozosvazqueze seomclinicalguidelinesforanaemiatreatmentincancerpatients2020
AT corraljaimej seomclinicalguidelinesforanaemiatreatmentincancerpatients2020
AT garciaescobari seomclinicalguidelinesforanaemiatreatmentincancerpatients2020
AT beatozambranoc seomclinicalguidelinesforanaemiatreatmentincancerpatients2020

Ejemplares similares